EXACT Therapeutics AS reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was NOK 0.454515 million compared to NOK 0.052 million a year ago. Net loss was NOK 40.1 million compared to NOK 58.59 million a year ago.

Basic loss per share from continuing operations was NOK 1.34 compared to NOK 1.95 a year ago. Diluted loss per share from continuing operations was NOK 1.34 compared to NOK 1.95 a year ago.